{"id":46461,"date":"2022-07-21T23:01:56","date_gmt":"2022-07-21T21:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/"},"modified":"2022-07-21T23:01:56","modified_gmt":"2022-07-21T21:01:56","slug":"butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/","title":{"rendered":"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022"},"content":{"rendered":"
\n

GUILFORD, Conn. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (\u201cButterfly\u201d), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens.\n<\/p>\n

<\/a><\/p>\n

\nDr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, Chief Financial Officer, will host a conference call and webcast at 8:30 am ET on August 3, 2022, to discuss second quarter 2022 financial results and operational progress.\n<\/p>\n

\nThe conference call will be broadcast live in listen-only mode via a webcast on Butterfly\u2019s Investor Relations website at Events & Presentations<\/b><\/a>.\n<\/p>\n

\nIndividuals interested in listening to the conference call on your telephone may do so by dialing approximately ten minutes prior to start time:\n<\/p>\n

\nUS domestic callers: +1 (844) 200-6205
\n
Outside US callers: +1 (929) 526-1599
\n
Access Code: 741669\n<\/p>\n

\nAfter the live webcast, the call will be archived on Butterfly\u2019s Investor Relations page.\n<\/p>\n

\nIn addition, a telephone replay of the call will be available until August 17, 2022, by dialing:\n<\/p>\n

\nUS domestic callers: +1 (866) 813-9403
\n
Outside US callers: +44 (204) 525-0658
\n
Access Code: 519795\n<\/p>\n

\nAbout Butterfly Network, Inc.<\/b>\n<\/p>\n

\nFounded by Dr. Jonathan Rothberg in 2011, and recently listed on the New York Stock Exchange through a business combination with Longview Acquisition Corp., Butterfly created the world’s first handheld, single probe whole-body ultrasound system using semiconductor technology, the Butterfly iQ+. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration of global health equity, making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Through its proprietary Ultrasound-on-Chip\u2122 technology, Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ can be purchased online today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ+ is a prescription device intended for qualified healthcare professionals only. For more information, visit www.butterflynetwork.com<\/b><\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestors<\/b>
Heather Getz
\n
610.316.5250
\n
hgetz@butterflynetwork.com<\/b><\/a>\n<\/p>\n

\nMedia<\/b>
Holly Spring
\n
781.888.8219
\n
hspring@butterflynetwork.com<\/b><\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

GUILFORD, Conn. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (\u201cButterfly\u201d), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens. Dr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46461","6":"format-standard","7":"category-industry"},"yoast_head":"\nButterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"GUILFORD, Conn. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (\u201cButterfly\u201d), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens. Dr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T21:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220721006013\/en\/1076489\/21\/Butterfly_logo_NiOH_Black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022\",\"datePublished\":\"2022-07-21T21:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/\"},\"wordCount\":362,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006013\\\/en\\\/1076489\\\/21\\\/Butterfly_logo_NiOH_Black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/\",\"name\":\"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006013\\\/en\\\/1076489\\\/21\\\/Butterfly_logo_NiOH_Black.jpg\",\"datePublished\":\"2022-07-21T21:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006013\\\/en\\\/1076489\\\/21\\\/Butterfly_logo_NiOH_Black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721006013\\\/en\\\/1076489\\\/21\\\/Butterfly_logo_NiOH_Black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/","og_locale":"en_US","og_type":"article","og_title":"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022 - Pharma Trend","og_description":"GUILFORD, Conn. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (\u201cButterfly\u201d), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens. Dr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-21T21:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220721006013\/en\/1076489\/21\/Butterfly_logo_NiOH_Black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022","datePublished":"2022-07-21T21:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/"},"wordCount":362,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721006013\/en\/1076489\/21\/Butterfly_logo_NiOH_Black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/","url":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/","name":"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721006013\/en\/1076489\/21\/Butterfly_logo_NiOH_Black.jpg","datePublished":"2022-07-21T21:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220721006013\/en\/1076489\/21\/Butterfly_logo_NiOH_Black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220721006013\/en\/1076489\/21\/Butterfly_logo_NiOH_Black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/butterfly-network-inc-to-report-second-quarter-2022-financial-results-on-august-3-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Butterfly Network, Inc. to Report Second Quarter 2022 Financial Results on August 3, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46461"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46461\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}